Antifungal Drugs Market Report by Drug Class (Azoles, Echinocandins, Polyenes, Allylamines, and Others), Indication (Dermatophytosis, Aspergillosis, Candidiasis, and Others), and Region 2024-2032
The global antifungal drugs market size reached US$ 15.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 20.1 Billion by 2032, exhibiting a growth rate (CAGR) of 3.1% during 2024-2032.
Antifungal drugs, or antimycotic drugs, refer to the pharmaceutical medicines used for the treatment of fungal infections on skin, hair and nails. Some of the commonly used antifungal drugs include polyenes, azoles and allylamines. They specifically neutralize fungal agents and dermatophytes, such as candida and tapeworms, and aid in the treatment of athlete’s foot, ringworm, aspergillosis, candidiasis and fungal meningitis. These drugs are commonly available in over the counter (OTC) capsule, gel, liquid and pill variants or intravenous solutions that are injected directly into the bloodstream to minimize and prevent fungal infection.
Antifungal Drugs Market Trends:
The increasing prevalence of fungal and nosocomial infections is one of the key factors creating a positive outlook for the market growth. Antifungal drugs are effective against both systemic and superficial infections that are acquired from exposure to contaminated surfaces in hospitals or humid conditions. Moreover, the convenient availability of OTC drugs in both urban and rural areas is providing a thrust to the market growth. With the rising health consciousness among the masses, consumers are increasingly opting for OTC therapeutics to timely treat minor infections. Additionally, various product innovations, such as the development of synthetic and semi-synthetic azole-based compounds for the treatment of invasive fungal infections, are acting as other growth-inducing factors. Pharmaceutical manufacturers are also investing extensively in the research and development (R&D) of novel therapeutics in the form of sprays, creams, tablets and injections with enhanced efficacy. Other factors, including significant growth in the pharmaceutical industry, along with the implementation of favorable government policies promoting public health, are anticipated to drive the market toward growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global antifungal drugs market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on drug class and indication.
Breakup by Drug Class:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Arcadia Consumer Healthcare Inc., Astellas Pharma Inc., Bayer AG, GlaxoSmithKline Plc, Merck & Co. Inc., Merck KGaA, Novartis AG, Pfizer Inc., Sanofi S.A. and Scynexis Inc.
Key Questions Answered in This Report
1. What was the size of the global antifungal drugs market in 2023?
2. What is the expected growth rate of the global antifungal drugs market during 2024-2032?
3. What has been the impact of COVID-19 on the global antifungal drugs market?
4. What are the key factors driving the global antifungal drugs market?
5. What is the breakup of the global antifungal drugs market based on the drug class?
6. What is the breakup of the global antifungal drugs market based on the indication?
7. What are the key regions in the global antifungal drugs market?
8. Who are the key players/companies in the global antifungal drugs market?
Antifungal drugs, or antimycotic drugs, refer to the pharmaceutical medicines used for the treatment of fungal infections on skin, hair and nails. Some of the commonly used antifungal drugs include polyenes, azoles and allylamines. They specifically neutralize fungal agents and dermatophytes, such as candida and tapeworms, and aid in the treatment of athlete’s foot, ringworm, aspergillosis, candidiasis and fungal meningitis. These drugs are commonly available in over the counter (OTC) capsule, gel, liquid and pill variants or intravenous solutions that are injected directly into the bloodstream to minimize and prevent fungal infection.
Antifungal Drugs Market Trends:
The increasing prevalence of fungal and nosocomial infections is one of the key factors creating a positive outlook for the market growth. Antifungal drugs are effective against both systemic and superficial infections that are acquired from exposure to contaminated surfaces in hospitals or humid conditions. Moreover, the convenient availability of OTC drugs in both urban and rural areas is providing a thrust to the market growth. With the rising health consciousness among the masses, consumers are increasingly opting for OTC therapeutics to timely treat minor infections. Additionally, various product innovations, such as the development of synthetic and semi-synthetic azole-based compounds for the treatment of invasive fungal infections, are acting as other growth-inducing factors. Pharmaceutical manufacturers are also investing extensively in the research and development (R&D) of novel therapeutics in the form of sprays, creams, tablets and injections with enhanced efficacy. Other factors, including significant growth in the pharmaceutical industry, along with the implementation of favorable government policies promoting public health, are anticipated to drive the market toward growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global antifungal drugs market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on drug class and indication.
Breakup by Drug Class:
- Azoles
- Voriconazole (Vfend)
- Posaconazole (Noxafil)
- Clotrimazole (Canesten)
- Isavuconazole (CRESEMBA)
- Others
- Echinocandins
- Caspofungin (Cancidas)
- Micafungin (Mycamine/ Funguard)
- Others
- Polyenes
- Amphotericin (AmBisome)
- Others
- Allylamines
- Terbinafine (Lamisil)
- Others
- Others
- Dermatophytosis
- Aspergillosis
- Candidiasis
- Invasive Candidiasis
- Vulvovaginal Candidiasis (VVC)
- Mouth/Throat/Esophageal Candidiasis
- Others
- Others
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Arcadia Consumer Healthcare Inc., Astellas Pharma Inc., Bayer AG, GlaxoSmithKline Plc, Merck & Co. Inc., Merck KGaA, Novartis AG, Pfizer Inc., Sanofi S.A. and Scynexis Inc.
Key Questions Answered in This Report
1. What was the size of the global antifungal drugs market in 2023?
2. What is the expected growth rate of the global antifungal drugs market during 2024-2032?
3. What has been the impact of COVID-19 on the global antifungal drugs market?
4. What are the key factors driving the global antifungal drugs market?
5. What is the breakup of the global antifungal drugs market based on the drug class?
6. What is the breakup of the global antifungal drugs market based on the indication?
7. What are the key regions in the global antifungal drugs market?
8. Who are the key players/companies in the global antifungal drugs market?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL ANTIFUNGAL DRUGS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY DRUG CLASS
6.1 Azoles
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Voriconazole (Vfend)
6.1.2.2 Posaconazole (Noxafil)
6.1.2.3 Clotrimazole (Canesten)
6.1.2.4 Isavuconazole (CRESEMBA)
6.1.2.5 Others
6.1.3 Market Forecast
6.2 Echinocandins
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Caspofungin (Cancidas)
6.2.2.2 Micafungin (Mycamine/ Funguard)
6.2.2.3 Others
6.2.3 Market Forecast
6.3 Polyenes
6.3.1 Market Trends
6.3.2 Key Segments
6.3.2.1 Amphotericin (AmBisome)
6.3.2.2 Others
6.3.3 Market Forecast
6.4 Allylamines
6.4.1 Market Trends
6.4.2 Key Segments
6.4.2.1 Terbinafine (Lamisil)
6.4.2.2 Others
6.4.3 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast
7 MARKET BREAKUP BY INDICATION
7.1 Dermatophytosis
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Aspergillosis
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Candidiasis
7.3.1 Market Trends
7.3.2 Key Segments
7.3.2.1 Invasive Candidiasis
7.3.2.2 Vulvovaginal Candidiasis (VVC)
7.3.2.3 Mouth/Throat/Esophageal Candidiasis
7.3.2.4 Others
7.3.3 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 MARKET BREAKUP BY REGION
8.1 North America
8.1.1 United States
8.1.1.1 Market Trends
8.1.1.2 Market Forecast
8.1.2 Canada
8.1.2.1 Market Trends
8.1.2.2 Market Forecast
8.2 Asia-Pacific
8.2.1 China
8.2.1.1 Market Trends
8.2.1.2 Market Forecast
8.2.2 Japan
8.2.2.1 Market Trends
8.2.2.2 Market Forecast
8.2.3 India
8.2.3.1 Market Trends
8.2.3.2 Market Forecast
8.2.4 South Korea
8.2.4.1 Market Trends
8.2.4.2 Market Forecast
8.2.5 Australia
8.2.5.1 Market Trends
8.2.5.2 Market Forecast
8.2.6 Indonesia
8.2.6.1 Market Trends
8.2.6.2 Market Forecast
8.2.7 Others
8.2.7.1 Market Trends
8.2.7.2 Market Forecast
8.3 Europe
8.3.1 Germany
8.3.1.1 Market Trends
8.3.1.2 Market Forecast
8.3.2 France
8.3.2.1 Market Trends
8.3.2.2 Market Forecast
8.3.3 United Kingdom
8.3.3.1 Market Trends
8.3.3.2 Market Forecast
8.3.4 Italy
8.3.4.1 Market Trends
8.3.4.2 Market Forecast
8.3.5 Spain
8.3.5.1 Market Trends
8.3.5.2 Market Forecast
8.3.6 Russia
8.3.6.1 Market Trends
8.3.6.2 Market Forecast
8.3.7 Others
8.3.7.1 Market Trends
8.3.7.2 Market Forecast
8.4 Latin America
8.4.1 Brazil
8.4.1.1 Market Trends
8.4.1.2 Market Forecast
8.4.2 Mexico
8.4.2.1 Market Trends
8.4.2.2 Market Forecast
8.4.3 Others
8.4.3.1 Market Trends
8.4.3.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Breakup by Country
8.5.3 Market Forecast
9 SWOT ANALYSIS
9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats
10 VALUE CHAIN ANALYSIS
11 PORTERS FIVE FORCES ANALYSIS
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes
12 PRICE ANALYSIS
13 COMPETITIVE LANDSCAPE
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 Abbott Laboratories
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Financials
13.3.1.4 SWOT Analysis
13.3.2 Arcadia Consumer Healthcare Inc.
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.3 Astellas Pharma Inc.
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.3.3 Financials
13.3.3.4 SWOT Analysis
13.3.4 Bayer AG
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.4.3 Financials
13.3.4.4 SWOT Analysis
13.3.5 GlaxoSmithKline Plc
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.5.3 Financials
13.3.6 Merck & Co. Inc.
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.6.3 Financials
13.3.6.4 SWOT Analysis
13.3.7 Merck KGaA
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.7.3 Financials
13.3.7.4 SWOT Analysis
13.3.8 Novartis AG
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.8.3 Financials
13.3.8.4 SWOT Analysis
13.3.9 Pfizer Inc.
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.9.3 Financials
13.3.9.4 SWOT Analysis
13.3.10 Sanofi S.A.
13.3.10.1 Company Overview
13.3.10.2 Product Portfolio
13.3.10.3 Financials
13.3.10.4 SWOT Analysis
13.3.11 Scynexis Inc.
13.3.11.1 Company Overview
13.3.11.2 Product Portfolio
13.3.11.3 Financials
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL ANTIFUNGAL DRUGS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY DRUG CLASS
6.1 Azoles
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Voriconazole (Vfend)
6.1.2.2 Posaconazole (Noxafil)
6.1.2.3 Clotrimazole (Canesten)
6.1.2.4 Isavuconazole (CRESEMBA)
6.1.2.5 Others
6.1.3 Market Forecast
6.2 Echinocandins
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Caspofungin (Cancidas)
6.2.2.2 Micafungin (Mycamine/ Funguard)
6.2.2.3 Others
6.2.3 Market Forecast
6.3 Polyenes
6.3.1 Market Trends
6.3.2 Key Segments
6.3.2.1 Amphotericin (AmBisome)
6.3.2.2 Others
6.3.3 Market Forecast
6.4 Allylamines
6.4.1 Market Trends
6.4.2 Key Segments
6.4.2.1 Terbinafine (Lamisil)
6.4.2.2 Others
6.4.3 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast
7 MARKET BREAKUP BY INDICATION
7.1 Dermatophytosis
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Aspergillosis
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Candidiasis
7.3.1 Market Trends
7.3.2 Key Segments
7.3.2.1 Invasive Candidiasis
7.3.2.2 Vulvovaginal Candidiasis (VVC)
7.3.2.3 Mouth/Throat/Esophageal Candidiasis
7.3.2.4 Others
7.3.3 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 MARKET BREAKUP BY REGION
8.1 North America
8.1.1 United States
8.1.1.1 Market Trends
8.1.1.2 Market Forecast
8.1.2 Canada
8.1.2.1 Market Trends
8.1.2.2 Market Forecast
8.2 Asia-Pacific
8.2.1 China
8.2.1.1 Market Trends
8.2.1.2 Market Forecast
8.2.2 Japan
8.2.2.1 Market Trends
8.2.2.2 Market Forecast
8.2.3 India
8.2.3.1 Market Trends
8.2.3.2 Market Forecast
8.2.4 South Korea
8.2.4.1 Market Trends
8.2.4.2 Market Forecast
8.2.5 Australia
8.2.5.1 Market Trends
8.2.5.2 Market Forecast
8.2.6 Indonesia
8.2.6.1 Market Trends
8.2.6.2 Market Forecast
8.2.7 Others
8.2.7.1 Market Trends
8.2.7.2 Market Forecast
8.3 Europe
8.3.1 Germany
8.3.1.1 Market Trends
8.3.1.2 Market Forecast
8.3.2 France
8.3.2.1 Market Trends
8.3.2.2 Market Forecast
8.3.3 United Kingdom
8.3.3.1 Market Trends
8.3.3.2 Market Forecast
8.3.4 Italy
8.3.4.1 Market Trends
8.3.4.2 Market Forecast
8.3.5 Spain
8.3.5.1 Market Trends
8.3.5.2 Market Forecast
8.3.6 Russia
8.3.6.1 Market Trends
8.3.6.2 Market Forecast
8.3.7 Others
8.3.7.1 Market Trends
8.3.7.2 Market Forecast
8.4 Latin America
8.4.1 Brazil
8.4.1.1 Market Trends
8.4.1.2 Market Forecast
8.4.2 Mexico
8.4.2.1 Market Trends
8.4.2.2 Market Forecast
8.4.3 Others
8.4.3.1 Market Trends
8.4.3.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Breakup by Country
8.5.3 Market Forecast
9 SWOT ANALYSIS
9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats
10 VALUE CHAIN ANALYSIS
11 PORTERS FIVE FORCES ANALYSIS
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes
12 PRICE ANALYSIS
13 COMPETITIVE LANDSCAPE
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 Abbott Laboratories
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Financials
13.3.1.4 SWOT Analysis
13.3.2 Arcadia Consumer Healthcare Inc.
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.3 Astellas Pharma Inc.
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.3.3 Financials
13.3.3.4 SWOT Analysis
13.3.4 Bayer AG
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.4.3 Financials
13.3.4.4 SWOT Analysis
13.3.5 GlaxoSmithKline Plc
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.5.3 Financials
13.3.6 Merck & Co. Inc.
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.6.3 Financials
13.3.6.4 SWOT Analysis
13.3.7 Merck KGaA
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.7.3 Financials
13.3.7.4 SWOT Analysis
13.3.8 Novartis AG
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.8.3 Financials
13.3.8.4 SWOT Analysis
13.3.9 Pfizer Inc.
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.9.3 Financials
13.3.9.4 SWOT Analysis
13.3.10 Sanofi S.A.
13.3.10.1 Company Overview
13.3.10.2 Product Portfolio
13.3.10.3 Financials
13.3.10.4 SWOT Analysis
13.3.11 Scynexis Inc.
13.3.11.1 Company Overview
13.3.11.2 Product Portfolio
13.3.11.3 Financials
LIST OF TABLES
Table 1: Global: Antifungal Drugs Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Antifungal Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2024-2032
Table 3: Global: Antifungal Drugs Market Forecast: Breakup by Indication (in Million US$), 2024-2032
Table 4: Global: Antifungal Drugs Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 5: Global: Antifungal Drugs Market: Competitive Structure
Table 6: Global: Antifungal Drugs Market: Key Players
Table 1: Global: Antifungal Drugs Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Antifungal Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2024-2032
Table 3: Global: Antifungal Drugs Market Forecast: Breakup by Indication (in Million US$), 2024-2032
Table 4: Global: Antifungal Drugs Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 5: Global: Antifungal Drugs Market: Competitive Structure
Table 6: Global: Antifungal Drugs Market: Key Players
LIST OF FIGURES
Figure 1: Global: Antifungal Drugs Market: Major Drivers and Challenges
Figure 2: Global: Antifungal Drugs Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Antifungal Drugs Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Antifungal Drugs Market: Breakup by Drug Class (in %), 2023
Figure 5: Global: Antifungal Drugs Market: Breakup by Indication (in %), 2023
Figure 6: Global: Antifungal Drugs Market: Breakup by Region (in %), 2023
Figure 7: Global: Antifungal Drugs (Azoles) Market: Sales Value (in Million US$), 2018 & 2023
Figure 8: Global: Antifungal Drugs (Azoles) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 9: Global: Antifungal Drugs (Echinocandins) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Antifungal Drugs (Echinocandins) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Antifungal Drugs (Polyenes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Antifungal Drugs (Polyenes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Antifungal Drugs (Allylamines) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Antifungal Drugs (Allylamines) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Antifungal Drugs (Other Drug Classes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Antifungal Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Antifungal Drugs (Dermatophytosis) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Antifungal Drugs (Dermatophytosis) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Antifungal Drugs (Aspergillosis) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Antifungal Drugs (Aspergillosis) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Antifungal Drugs (Candidiasis) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Antifungal Drugs (Candidiasis) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Antifungal Drugs (Other Indications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Antifungal Drugs (Other Indications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: North America: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: North America: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: United States: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: United States: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Canada: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Canada: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Asia-Pacific: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Asia-Pacific: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: China: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: China: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Japan: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Japan: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: India: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: India: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: South Korea: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: South Korea: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: Australia: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: Australia: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: Indonesia: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: Indonesia: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: Others: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: Others: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: Europe: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: Europe: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: Germany: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: Germany: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: France: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: France: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: United Kingdom: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: United Kingdom: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: Italy: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: Italy: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: Spain: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: Spain: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: Russia: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: Russia: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: Others: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: Others: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: Latin America: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: Latin America: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: Brazil: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: Brazil: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: Mexico: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: Mexico: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: Others: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: Others: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Middle East and Africa: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Middle East and Africa: Antifungal Drugs Market: Breakup by Country (in %), 2023
Figure 73: Middle East and Africa: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Global: Antifungal Drugs Industry: SWOT Analysis
Figure 75: Global: Antifungal Drugs Industry: Value Chain Analysis
Figure 76: Global: Antifungal Drugs Industry: Porter's Five Forces Analysis
Figure 1: Global: Antifungal Drugs Market: Major Drivers and Challenges
Figure 2: Global: Antifungal Drugs Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Antifungal Drugs Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Antifungal Drugs Market: Breakup by Drug Class (in %), 2023
Figure 5: Global: Antifungal Drugs Market: Breakup by Indication (in %), 2023
Figure 6: Global: Antifungal Drugs Market: Breakup by Region (in %), 2023
Figure 7: Global: Antifungal Drugs (Azoles) Market: Sales Value (in Million US$), 2018 & 2023
Figure 8: Global: Antifungal Drugs (Azoles) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 9: Global: Antifungal Drugs (Echinocandins) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Antifungal Drugs (Echinocandins) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Antifungal Drugs (Polyenes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Antifungal Drugs (Polyenes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Antifungal Drugs (Allylamines) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Antifungal Drugs (Allylamines) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Antifungal Drugs (Other Drug Classes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Antifungal Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Antifungal Drugs (Dermatophytosis) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Antifungal Drugs (Dermatophytosis) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Antifungal Drugs (Aspergillosis) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Antifungal Drugs (Aspergillosis) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Antifungal Drugs (Candidiasis) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Antifungal Drugs (Candidiasis) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Antifungal Drugs (Other Indications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Antifungal Drugs (Other Indications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: North America: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: North America: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: United States: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: United States: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Canada: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Canada: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Asia-Pacific: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Asia-Pacific: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: China: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: China: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Japan: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Japan: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: India: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: India: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: South Korea: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: South Korea: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: Australia: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: Australia: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: Indonesia: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: Indonesia: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: Others: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: Others: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: Europe: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: Europe: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: Germany: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: Germany: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: France: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: France: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: United Kingdom: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: United Kingdom: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: Italy: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: Italy: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: Spain: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: Spain: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: Russia: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: Russia: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: Others: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: Others: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: Latin America: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: Latin America: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: Brazil: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: Brazil: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: Mexico: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: Mexico: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: Others: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: Others: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Middle East and Africa: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Middle East and Africa: Antifungal Drugs Market: Breakup by Country (in %), 2023
Figure 73: Middle East and Africa: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Global: Antifungal Drugs Industry: SWOT Analysis
Figure 75: Global: Antifungal Drugs Industry: Value Chain Analysis
Figure 76: Global: Antifungal Drugs Industry: Porter's Five Forces Analysis
